Evidence map›Paper›PMID 37082754›Full record

ArticleACS pharmacology & translational science2023

Receptor Binding Profiles for Tryptamine Psychedelics and Effects of 4-Propionoxy-

Grant C Glatfelter, Marilyn Naeem, Duyen N K Pham, James A Golen, Andrew R Chadeayne, David R Manke, Michael H Baumann

Open access · greenAbstract read
In one paragraph

Article in ACS pharmacology & translational science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 22 citations in OpenAlex.

  1. αMolecular psychiatry · 2026
    Article
  2. Crystal structures of new psychoactive substances 4-HO-DET and 4-AcO-DET.Acta crystallographica. Section E, Crystallographic communications · 2026
    Article
  3. Moving beyond 5-HTPsychopharmacology · 2026
    Article
  4. Article
  5. Explainable Artificial Intelligence (xAI) for 5-HTMolecules (Basel, Switzerland) · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. 4-Hy-droxy-IUCrData · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Grant C GlatfelterDesigner Drug Research Unit, National Institute on Drug Abuse, Intramural Research Program, Baltimore, Maryland 21224 United States.ORCID https://orcid.org/0000-0003-1011-9083
Marilyn NaeemDepartment of Chemistry and Biochemistry, University of Massachusetts Dartmouth, North Dartmouth, Massachusetts 02747, United States.
Duyen N K PhamDepartment of Chemistry and Biochemistry, University of Massachusetts Dartmouth, North Dartmouth, Massachusetts 02747, United States.
James A GolenDepartment of Chemistry and Biochemistry, University of Massachusetts Dartmouth, North Dartmouth, Massachusetts 02747, United States.
Andrew R ChadeayneCaaMTech, Inc., Issaquah, Washington 98027, United States.
David R MankeDepartment of Chemistry and Biochemistry, University of Massachusetts Dartmouth, North Dartmouth, Massachusetts 02747, United States.ORCID https://orcid.org/0000-0002-2513-4801
Michael H BaumannDesigner Drug Research Unit, National Institute on Drug Abuse, Intramural Research Program, Baltimore, Maryland 21224 United States.ORCID https://orcid.org/0000-0001-7758-1470
University of Massachusetts Dartmouth · USNational Institute on Drug Abuse · US

Funding

Preclinical medication development for stimulant use disorderZIADA000522 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI BAUMANN, MICHAEL · 2009 to 2025
$8.9M
Development of Dual Dopamine/Serotonin Releasing AgentsZ01DA000522 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI ROTHMAN, RICHARD · 2008 to 2008
$598k
Intramural NIH HHS Z01 DA000522
6 · The paper itself

Abstract

Analogues of 4-phosphoryloxy-

Identifiers

PMID37082754
PMCPMC10111620
OpenAlexW4323825498

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.